Trial Profile
Phase I single ascending dose study in healthy volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 09 May 2015
Price :
$35
*
At a glance
- Drugs Lasofoxifene (Primary)
- Indications Hypogonadism
- Focus Adverse reactions
- Sponsors Pfizer
- 09 May 2015 New trial record